Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-15 Sale | 2022-03-17 5:58 pm | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 8,698 | $7.6326 | $66,388 | 120,430 (Direct) | View |
| 2021-03-15 Sale | 2021-03-17 5:00 pm | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 6,164 | $38.14 | $235,089 | 102,574 (Direct) | View |
| 2020-10-12 Sale | 2020-10-13 4:34 pm | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 35,264 | $42 | $1,481,088 | 1,279,319 (Direct) | View |
| 2020-10-08 Sale | 2020-10-09 5:49 pm | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 44,574 | $41 | $1,827,534 | 1,369,015 (Direct) | View |
| 2020-10-06 Sale | 2020-10-08 5:03 pm | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 44,574 | $40 | $1,782,960 | 768,167 (Direct) | View |
| 2020-03-16 Sale | 2020-03-18 4:32 pm | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 3,750 | $19.19 | $71,980 | 63,021 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-21 Option Award | 2024-10-22 8:18 pm | N/A 2034-10-20 | Artiva Biotherapeutics Inc. | ARTV | MOORE ALISON Director | 27,500 | $0 | 27,500 (Direct) | View |
| 2024-10-10 Option Award | 2024-10-10 6:20 pm | N/A 2034-10-10 | CODEXIS INC. | CDXS | MOORE ALISON Chief Technical Officer | 350,000 | $0 | 448,696 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-13 6:27 pm | N/A N/A | CODEXIS INC. | CDXS | MOORE ALISON Director | 30,120 | $0 | 98,696 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:09 pm | N/A N/A | CODEXIS INC. | CDXS | MOORE ALISON Director | 34,602 | $0 | 68,576 (Direct) | View |
| 2023-03-22 Option Award | 2023-03-24 8:19 pm | N/A 2033-03-22 | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 990,832 | $0 | 1,105,469 (Direct) | View |
| 2023-03-14 Tax Withholding | 2023-03-16 4:49 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 8,351 | $5.5071 | 114,637 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 4:10 pm | N/A N/A | CODEXIS INC. | CDXS | MOORE ALISON Director | 11,273 | $0 | 33,974 (Direct) | View |
| 2022-03-23 Option Award | 2022-03-25 5:51 pm | N/A 2032-03-23 | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 737,179 | $0 | 737,179 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 4:15 pm | N/A N/A | CODEXIS INC. | CDXS | MOORE ALISON Director | 4,796 | $0 | 22,701 (Direct) | View |
| 2021-03-26 Option Award | 2021-03-30 4:53 pm | N/A 2031-03-26 | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 117,231 | $0 | 219,805 (Direct) | View |
| 2020-10-12 Exercise | 2020-10-13 4:34 pm | N/A 2028-06-25 | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 35,264 | $0 | 1,279,319 (Direct) | View |
| 2020-10-12 Exercise | 2020-10-13 4:34 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 35,264 | $2.27 | 1,279,319 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-09 5:49 pm | N/A 2028-06-25 | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 35,264 | $0 | 1,369,015 (Direct) | View |
| 2020-10-08 Exercise | 2020-10-09 5:49 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 35,264 | $2.27 | 1,369,015 (Direct) | View |
| 2020-10-06 Exercise | 2020-10-08 5:03 pm | N/A 2028-06-25 | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 35,264 | $0 | 768,167 (Direct) | View |
| 2020-10-06 Exercise | 2020-10-08 5:03 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 35,264 | $2.27 | 768,167 (Direct) | View |
| 2020-08-13 Exercise | 2020-08-14 4:04 pm | N/A 2028-06-25 | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 32,451 | $0 | 812,023 (Direct) | View |
| 2020-08-13 Exercise | 2020-08-14 4:04 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 32,451 | $2.27 | 812,023 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 4:10 pm | N/A N/A | CODEXIS INC. | CDXS | MOORE ALISON Director | 17,905 | $0 | 17,905 (Direct) | View |
| 2020-03-18 Option Award | 2020-03-20 4:37 pm | N/A 2030-03-17 | Allogene Therapeutics Inc. | ALLO | MOORE ALISON Chief Technical Officer | 140,400 | $0 | 203,421 (Direct) | View |